Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Siga Technologies Inc (SIGA)

Siga Technologies Inc (SIGA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.

Fiscal Year End Date: 12/31

(Values in U.S. Thousands) Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019
Sales 139,920 110,780 133,670 124,960 26,740
Sales Growth +26.30% -17.12% +6.97% +367.31% -94.39%
Net Income 68,070 33,900 69,450 56,340 -7,240
Net Income Growth +100.80% -51.19% +23.27% +878.18% -101.72%
(Values in U.S. Thousands) Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019
Total Assets 254,350 195,040 214,730 149,830 198,570
Total Assets Growth +30.41% -9.17% +43.32% -24.55% -2.39%
Total Liabilities 57,490 24,880 40,410 20,040 100,780
Total Liabilities Growth +131.07% -38.43% +101.65% -80.12% +0.25%
(Values in U.S. Thousands) Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2019
Operating Cash Flow 94,800 41,610 11,490 71,520 -18,200
Operating Cash Flow Growth +127.83% +262.14% -83.93% +492.97% -126.43%
Net Cash Flow 51,360 -4,350 -14,750 -43,100 -19,410
Change in Net Cash Flow +1,280.69% +70.51% +65.78% -122.05% -113.55%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar